Barbara Klencke

Insider Reports History

Entity
Individual
Location
C/O Sierra Oncology, Inc., 1820 Gateway Drive, Suite 110, San Mateo, CA
Signature
/s/ Shelly Pinto, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Klencke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TScan Therapeutics, Inc. Director Voting Common Stock 45K $238K $5.29 Sep 23, 2024 Direct
TScan Therapeutics, Inc. Director Voting Common Stock 30K $149K $4.97 Dec 14, 2023 Direct
Xencor Inc Director Common Stock 5.99K $141K $23.58 Jun 13, 2024 Direct
TScan Therapeutics, Inc. Director Voting Common Stock 25K $132K $5.29 Sep 23, 2024 By Trust
TScan Therapeutics, Inc. Director Voting Common Stock 25K $124K $4.97 Dec 14, 2023 By Trust
ALX ONCOLOGY HOLDINGS INC Director Common Stock 60K $108K $1.80 Jan 21, 2025 Direct
ALX ONCOLOGY HOLDINGS INC Director Common Stock 60K $108K $1.80 Jan 21, 2025 Indirect
TScan Therapeutics, Inc. Director Stock Option (Right to Buy) 47.5K Jun 12, 2024 Direct
ALX ONCOLOGY HOLDINGS INC Director Stock Option (right to buy) 40.4K Jan 21, 2025 Direct
Xencor Inc Director Stock Option (Right to Buy) 12K Jun 13, 2024 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 Jun 13, 2024 Direct
Sierra Oncology, Inc. Chief Medical Officer Common Stock 0 $55.00 Jul 1, 2022 By spouse
Sierra Oncology, Inc. Chief Medical Officer Common Stock 0 $55.00 Jul 1, 2022 Direct
Sierra Oncology, Inc. Chief Medical Officer Stock Option (right to buy) 0 Jul 1, 2022 Direct

Insider Reports Filed by Barbara Klencke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALXO ALX ONCOLOGY HOLDINGS INC Jan 21, 2025 1 $0 4 Jan 23, 2025 Director
ALXO ALX ONCOLOGY HOLDINGS INC Jan 21, 2025 0 $0 3 Jan 23, 2025 Director
TCRX TScan Therapeutics, Inc. Sep 23, 2024 1 $26.5K 4 Sep 24, 2024 Director
TCRX TScan Therapeutics, Inc. Aug 23, 2024 2 $56.1K 4 Aug 27, 2024 Director
XNCR Xencor Inc Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 13, 2024 Director
TCRX TScan Therapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 19, 2024 1 $0 4 Feb 21, 2024 Director
TCRX TScan Therapeutics, Inc. Dec 14, 2023 1 $25.4K 4 Dec 18, 2023 Director
XNCR Xencor Inc Sep 15, 2023 1 $0 4 Sep 19, 2023 Director
XNCR Xencor Inc Sep 15, 2023 0 $0 3 Sep 19, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 22, 2023 Director
TCRX TScan Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
TCRX TScan Therapeutics, Inc. Apr 6, 2023 1 $0 4 Apr 10, 2023 Director
TCRX TScan Therapeutics, Inc. Apr 6, 2023 0 $0 3 Apr 10, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Jan 20, 2023 1 $0 4 Jan 24, 2023 Director
SRRA Sierra Oncology, Inc. Jul 1, 2022 12 -$825K 4 Jul 1, 2022 Chief Medical Officer
SRRA Sierra Oncology, Inc. Jun 17, 2022 1 $0 4 Jun 17, 2022 Chief Medical Officer
EFTR eFFECTOR Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
SRRA Sierra Oncology, Inc. Mar 14, 2022 1 $0 4 Mar 14, 2022 Chief Medical Officer
SRRA Sierra Oncology, Inc. Jan 28, 2022 1 $0 4 Jan 28, 2022 Chief Medical Officer
EFTR eFFECTOR Therapeutics, Inc. Nov 1, 2021 1 $0 4 Nov 2, 2021 Director
EFTR eFFECTOR Therapeutics, Inc. Nov 1, 2021 0 $0 3 Nov 2, 2021 Director